Comparison of At-Home Versus In-Clinic Receipt of Long-Acting Injectable Cabotegravir/Rilpivirine
At-home administration of LA CAB/RPV by a healthcare provider was comparably safe, effective, and associated with high participant satisfaction relative to in-clinic administration.
Authors
- Mulugeta Gebregziabher (ORCID: https://orcid.org/0000-0002-4826-481X)
- Virginia A. Fonner (ORCID: https://orcid.org/0000-0002-9005-3549)
- Eric G. Meissner (ORCID: https://orcid.org/0000-0002-5240-7115)
- Jamila Williams
- Stephanie Kirk
- Christina B. Young (ORCID: https://orcid.org/0000-0001-9535-2137)
- Angela Moreland
- Rochelle F. Hanson (ORCID: https://orcid.org/0000-0002-6362-0720)
- Hayley Berry
Institutions
- Family Health International 360 (US)
- Medical University of South Carolina (US)
- Ralph H. Johnson VA Medical Center (US)
Publication Details
- Journal
- Clinical Infectious Diseases
- Published
- 2024-10-08
- DOI
- https://doi.org/10.1093/cid/ciae472
- Citations
- 8
- Primary Topic
- HIV/AIDS Research and Interventions
- Type
- article
- Field-Weighted Citation Impact
- 3.11
Funders
- U.S. Department of Health and Human Services
- Medical University of South Carolina
- ViiV Healthcare
- Norges Idrettshøgskole
- National Institutes of Health
- Health Resources and Services Administration
- South Carolina Clinical and Translational Research Institute, Medical University of South Carolina
- National Institute of General Medical Sciences
- National Institute of Diabetes and Digestive and Kidney Diseases
- National Center for Advancing Translational Sciences